Funding Priority

Translate Research into Results

Because of our many interdisciplinary strengths, we have the ability to convert breakthroughs in labs into novel treatments in clinical trials much more rapidly than other institutions. Strengthening these capabilities will lead to more effective therapies, and ensure that our patients have access to more personalized, more advanced and more compassionate treatments. We will continue to provide holistic support and address the needs of all patients and families throughout their entire cancer journey.

UNC Lineberger Comprehensive Cancer Center

    Setting the Pace

    Twenty miles into the Boston Marathon, a notorious ascent tests the wills of thousands of runners: Heartbreak Hill.

    It’s not actually that steep, but standing in the way of the race’s fi nal miles, it lives up to its infamous name. For Amy Charney of Carrboro, North Carolina, it wouldn’t be the only heartbreak she would have to endure on her way to the fi nish line. Shortly after qualifying for the 2015 Boston Marathon, Amy was diagnosed with breast cancer, and the treatment plan would include months of chemotherapy. But running was her passion, and she was determined not to let her diagnosis keep her from a lifelong goal.

    At UNC Lineberger, we are motivated by patients like Amy. That’s why we invest in physicians, researchers and clinical programs that can propagate the latest and most life-changing treatments. With hundreds of clinical trials, our research enables us to attack specific forms of cancer as strategically as possible, and in Amy’s case, this meant a chance to toe the starting line. At the UNC Breast Center, experts work together to bring the latest in diagnostics and treatments to bear on a patient’s cancer. This prowess led Amy to world-renowned specialist UNC Breast Center’s Lisa Carey, M.D.

    Amy’s clinical trial involved a targeted chemotherapy drug called trastuzumab emtansine that goes only to the cancer instead of throughout the body. Known as a “Trojan Horse” treatment, it has fewer side-effects that the typical aggressive regimen. And it allowed Amy to take on the 26.2-mile race while undergoing treatment.

    Thanks to our patient-focused care teams and clinical excellence, Amy Charney’s Boston Marathon dream became a reality.

    Return to main pageOpens in new window


    More UNC Lineberger Funding Priorities

    Explore Stories

    Rich Preyer and Marilyn Jacobs Preyer

    Reducing Breast Cancer Disparities And Barriers To Care

    Rich Preyer and Marilyn Jacobs Preyer have donated $1 million to support UNC Lineberger Comprehensive Cancer Center’s Carolina Breast Cancer Study


    Grateful patient and husband establish breast cancer research fund

    Ensuring access to the most advanced care


    Deepening Our Understanding

    Using next generation sequencing to better understand COVID-19


    Precision Cancer Treatments

    "It's an exciting approach; we hit the tumor hard with little toxicity, leaving room for other therapy."

    Shelley Earp unc Lineberger

    Advancing Cancer Research and Care Across Carolina and the Globe

    As a nationally recognized cancer researcher and current director of UNC Lineberger Comprehensive Care Center, Shelton “Shelley” Earp is as comfortable in the lab as he is cheering for the Tar Heels in the Dean Dome.


    Breaking Down Precision Medicine

    UNC Lineberger designs, develops and delivers CAR-T therapy to to attack cancers.